SpyGlass Pharma, Inc. (SGP)
26.28
-0.14
(-0.53%)
USD |
NASDAQ |
Aug 31, 15:09
SpyGlass Pharma Shareholders Equity (Quarterly) : 232.36M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 232.36M |
| March 31, 2026 | 250.11M |
| December 31, 2025 | 105.70M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 12.07M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 243.43M |
| Total Liabilities (Quarterly) | 11.07M |
| Debt to Equity Ratio | 0.007 |
| Current Ratio | 25.06 |
| Net Debt Paydown Yield | 0.06% |